0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe — RxCUI 2613763
RxNorm drug concept · Semantic clinical drug
RxCUI 2613763
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2613763
Official name0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspegfilgrastim-fpgk 6 MG per 0.6 ML Prefilled Syringe; pegfilgrastim-fpgk 6 MG in 0.6 ML Prefilled Syringe
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,023 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pegfilgrastim Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Chemotherapy works by targeting fast-growing cells — but that includes the cells in your bone marrow that make white blood cells. When white blood cell counts drop too low, your bo...
- Why do I need this injection if I'm already getting chemotherapy?
- It's given as a shot just under the skin — subcutaneously. Depending on the product and your situation, you might receive it via a manual prefilled syringe, or with the Neulasta on...
- The most common side effects are bone pain and aching in your arms and legs — your bones are working harder to produce white blood cells, so some discomfort is normal. But call you...
🕸️ Concept Web — How 0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syr... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe
RxCUI 2613763 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Pegfilgrastim
338036IN -
Pegfilgrastim-fpgk
2613761PIN
-
Pegfilgrastim
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Stimufend
2613765BN
-
Stimufend
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pegfilgrastim Prefilled Syringe
727538SCDF -
Pegfilgrastim-fpgk Prefilled Syringe
2645690SCDFP -
Pegfilgrastim Injectable Product
1161380SCDG -
Pegfilgrastim-fpgk Injectable Product
2663333SCDGP -
Pegfilgrastim Prefilled Syringe [Stimufend]
2613768SBDF -
Pegfilgrastim-fpgk Prefilled Syringe [Stimufend]
2655177SBDFP -
Stimufend Injectable Product
2613767SBDG -
Prefilled Syringe
721656DF - +1 more in this family
-
Pegfilgrastim Prefilled Syringe
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pegfilgrastim-fpgk 10 MG/ML
2613762SCDC -
0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe [Stimufend]
2613769SBD -
Pegfilgrastim-fpgk 10 MG/ML [Stimufend]
2613766SBDC
-
Pegfilgrastim-fpgk 10 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pegfilgrastim-fpgk 10 MG/ML
SCDC · 2613762 -
Pegfilgrastim Prefilled Syringe
SCDF · 727538 -
Pegfilgrastim-fpgk Prefilled Syringe
SCDFP · 2645690 -
Pegfilgrastim Injectable Product
SCDG · 1161380 -
Pegfilgrastim-fpgk Injectable Product
SCDGP · 2663333
Brand-Name Concepts
-
0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe [Stimufend]
SBD · 2613769 -
Pegfilgrastim-fpgk 10 MG/ML [Stimufend]
SBDC · 2613766 -
Pegfilgrastim Prefilled Syringe [Stimufend]
SBDF · 2613768 -
Pegfilgrastim-fpgk Prefilled Syringe [Stimufend]
SBDFP · 2655177 -
Stimufend Injectable Product
SBDG · 2613767 -
Stimufend
BN · 2613765
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 2613763 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65219-0371-10 | 1 BLISTER PACK in 1 CARTON (65219-371-10) / 1 SYRINGE in 1... | STIMUFEND | Fresenius Kabi USA, LLC | 2022-10-06 |
| 72603-0402-01 | 1 BLISTER PACK in 1 CARTON (72603-402-01) / 1 SYRINGE in 1... | STIMUFEND | NORTHSTAR RX LLC | 2025-12-29 |
Observed labelers:
Fresenius Kabi USA, LLC (1) ·
NORTHSTAR RX LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| Q5127 | Inj, stimufend, 0.5 mg | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.